|
2025
|
Invention
|
Compositions comprising a tn3 scaffold and methods of using the same.
The present invention prov... |
|
2024
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome. Prov... |
|
|
Invention
|
Cd40l-specific tn3-derived scaffolds for use in the treatment and prevention of rheumatoid arthri... |
|
|
Invention
|
Cd40l antagonist and uses thereof.
A human CD40L-specific Tn3 molecule and therapeutic uses ther... |
|
|
Invention
|
Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjögren's syndrome.
Pro... |
|
|
Invention
|
Inebilizumab and methods of using the same in the treatment or prevention of igg4-related disease... |
|
|
Invention
|
Anti-cd19 binding agents for the treatment and prevention of immune mediated necrotizing myopathy... |
|
|
Invention
|
Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoim... |
|
|
Invention
|
Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjögren's syndrome. Prov... |
|
2023
|
P/S
|
Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disor... |
|
|
Invention
|
Cd40l antagonist and uses thereof in the treatment of lupus nephritis.
A human CD40L-specific Tn... |
|
|
P/S
|
Medical services, namely, providing internet-based medical information for patients on Medical is... |
|
|
Invention
|
Formulations comprising an immunoglobulin-like transcript 7 (ilt7)-binding protein. Provided are ... |
|
|
Invention
|
Ilt7 binding molecules and methods of using the same.
The present invention is directed to ILT7 ... |
|
|
Invention
|
Use of an anti-cd19 antibody to treat autoimmune disease.
Methods for using an anti-CD19 antibod... |
|
2022
|
Invention
|
Methods of treating neuromyelitis optica spectrum disorder.
Methods of treating neuromyelitis op... |
|
|
Invention
|
Methods of treating immune mediated pulmonary injury.
The present disclosure relates to methods ... |
|
|
Invention
|
Inebilizumab and methods of using the same for sustained b-cell depletion. Compositions and metho... |
|
|
Invention
|
Methods of treatment using ilt7 binding proteins.
The present disclosure is related to methods o... |
|
|
Invention
|
Cd40l antagonist and uses thereof in the treatment of lupus nephritis. A human CD40L-specific Tn3... |
|
|
Invention
|
Use of an anti-cd19 antibody to treat myasthenia gravis.
Methods for using an anti-CD19 antibody... |
|
|
Invention
|
Use of an anti-cd19 antibody to treat myasthenia gravis. Methods for using an anti-CD19 antibody ... |
|
|
Invention
|
Methods of treatment of autoimmune disorders using ilt7 binding proteins.
The present disclosure... |
|
|
Invention
|
Methods of treatment of autoimmune disorders using ilt7 binding proteins. The present disclosure ... |
|
2021
|
P/S
|
Medicines for human purposes; pharmaceutical preparations. Providing information to patients and ... |
|
|
Invention
|
Use of an anti-cd19 antibody to treat autoimmune disease. Methods for using an anti-CD19 antibody... |
|
|
P/S
|
Pharmaceutical products for the treatment of rare autoimmune
diseases and disorders. |
|
|
Invention
|
Methods of administering a composition comprising a tn3 scaffold and a cd40l-specific monomer. Th... |
|
|
Invention
|
Immunocytokines for treatment of autoimmune and inflammatory conditions. The present disclosure i... |
|
|
Invention
|
Methods of treating neuromyelitis optica spectrum disorder. e.ge.g., by serum glial fibrillary ac... |
|
|
Invention
|
Ilt7 binding molecules and methods of using the same. The present invention is directed to ILT7 b... |
|
|
Invention
|
Methods of treating immune mediated pulmonary injury. The present disclosure relates to methods f... |
|
2020
|
Invention
|
Methods of treatment using ilt7 binding proteins. The present disclosure is related to methods of... |
|
|
P/S
|
Pharmaceutical products for the treatment of rare autoimmune diseases and disorders. |
|
2019
|
Invention
|
Cd40l antagonist and uses thereof. A human CD40L-specific Tn3 molecule and therapeutic uses thereof. |
|
|
P/S
|
Pharmaceutical products for the treatment of rare autoimmune diseases and disorders |
|
|
Invention
|
Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and u... |
|
|
P/S
|
Pharmaceutical products for the treatment of rare autoimmune diseases and disorders |
|
2018
|
P/S
|
Research and development in the field of inflammation and autoimmune diseases; clinical trials fo... |
|
|
P/S
|
Pharmaceutical products for the treatment of rare autoimmune diseases and disorders. Research and... |
|
|
Invention
|
Nucleic acids encoding a tn3 scaffold comprising a cd40l-specific monomer subunit. The present in... |
|
2012
|
Invention
|
Humanized anti-cd19 antibodies. Isolated nucleic acids encoding anti-CD19 mouse monoclonal antibo... |
|
|
Invention
|
Cd40l-specific tn3-derived scaffolds and methods of use thereof. The present invention provides T... |
